Tumor Radiation Therapy Market Report 2025 (Global Edition)

Global Tumor Radiation Therapy Market Report 2024 Market Size Split by Type (External Beam Radiation Therapy, Systemic Radiation therapy, Internal Beam Radiation Therapy), by Application (Skin and Lip...

Tumor Radiation Therapy Market Report Description

We have various report editions of Tumor Radiation Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Tumor Radiation Therapy Market Insights Video

Competitive Landscape of the Tumor Radiation Therapy Market

The Tumor Radiation Therapy Market is a dynamic environment with a variety of competitors striving for market dominance. Companies are constantly looking for ways to expand their reach with strategies such as innovative product launches and strategic partnerships. Key players include established medical device manufacturers, specialized radiation therapy providers, and rising startups that are bringing new and improved tumor radiation therapy solutions to the market.

June 2024: Mevion Medical Systems announced a collaboration with Atlantic Health System to install a MEVION S250-FIT Proton Therapy System at the Carol G. Simon Cancer Center in Morristown Medical Center, New Jersey. This proton therapy system is scheduled to be installed in 2025 and will provide advanced radiation oncology services to patients. Proton therapy is an advanced form of radiation therapy that targets tumors more precisely compared to conventional photon therapy, minimizing damage to surrounding healthy tissue. (Source: https://mevion.com/press-release/mevion-atlantic-health) May 2024: Varian, a Siemens Healthineers company, highlighted its advancements in artificial intelligence and advanced therapies, including radiation therapy designed to improve cancer treatment and patient care in ESTRO (European Society for Radiotherapy and Oncology) 2024. (Source: https://www.siemens-healthineers.com/press/releases/varian-estro-2024)

Top Companies Market Share in Tumor Radiation Therapy Industry: (In no particular order of Rank)

• Nordion Inc.
• Siemens Healthineers
• Mevion Medical Systems
• Inc.
• IsoRay
• Inc.
• iCAD
• Inc.
• Becton
• Dickinson and Company
• Ion Beam Applications SA
• Elekta AB
• Eckert & Ziegler Group
• Accuray Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Tumor Radiation Therapy Market

Which Region will dominate the Tumor Radiation Therapy Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global due to the rising incidence of cancer across the region, as more patients require effective treatment options. The high prevalence of advanced healthcare infrastructure, coupled with substantial investments in medical technology, enables the adoption of cutting-edge radiation therapy techniques such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT). Additionally, the strong presence of key market players and continuous innovations in radiation equipment enhance market growth. Government initiatives and funding for cancer research and treatment also play a crucial role in supporting the market. The growing awareness among patients and healthcare providers about the benefits of radiation therapy further fuels demand. Moreover, the increasing availability of skilled professionals and comprehensive training programs ensures the effective delivery of these advanced treatments.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Tumor Radiation Therapy Market due to the increasing incidence of cancer in countries like China, India, and Japan is a significant driver, propelled by factors such as population aging, urbanization, and changing lifestyles. Moreover, rapid advancements in healthcare infrastructure and technology adoption are expanding access to radiation therapy treatments. Countries in Asia Pacific are investing heavily in upgrading medical facilities and incorporating advanced radiation therapy equipment, enhancing treatment capabilities and patient outcomes. Additionally, government initiatives and healthcare reforms aimed at improving cancer care and treatment accessibility further stimulate market growth. Policies promoting healthcare investments, research collaborations, and public-private partnerships contribute to the expansion of radiation therapy services across the region.

 

The current report Scope analyzes Tumor Radiation Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Tumor Radiation Therapy

According to Cognitive Market Research, the global Tumor Radiation Therapy Market size was estimated at USD 1056.25 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 422.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Tumor Radiation Therapy market with a market size of USD 333.35 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. The demand is amplified by the high prevalence of cancer in the US.
• The Canada Tumor Radiation Therapy Market had a market share of USD 50.70 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The robust government funding and support for cancer research and treatment in Canada is a significant driver propelling the growth of the market.
• The Mexico Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 38.45 million in 2024.

Europe Tumor Radiation Therapy

According to Cognitive Market Research, the global Tumor Radiation Therapy Market size was estimated at USD 1056.25 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 316.88 million in 2024 and will grow to a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Tumor Radiation Therapy Market had a market share of USD 53.24 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, Tumor Radiation Therapy sales witness an upswing due to the expanding access to advanced radiation therapy technologies and treatment facilities
• The France Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 29.15 million in 2024.
• According to Cognitive Market Research, the Germany Tumor Radiation Therapy Market size was valued at USD 62.74 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. Germany's strong healthcare infrastructure and focus on research and development significantly drive the growth of the Tumor Radiation Therapy market.
• The Italy Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 27.25 million in 2024.
• The Russia Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 49.12 million in 2024.
• The Spain Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 25.98 million in 2024
• The Luxembourg Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 9.82 million in 2024.
• The Portugal Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 6.65 million in 2024.
• The Greece Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 3.80 million in 2024.
• The Rest of Europe's Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 49.12 million in 2024.

Asia Pacific Tumor Radiation Therapy

According to Cognitive Market Research, the global Tumor Radiation Therapy Market size was estimated at USD 1056.25 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 242.94 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Tumor Radiation Therapy Market size was valued at USD 109.32 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Tumor Radiation Therapy sales surged in China due to government initiatives and healthcare reforms aimed at improving cancer care infrastructure and increasing access to advanced medical technologies.
• The Japan Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 33.53 million in 2024.
• The India Tumor Radiation Therapy Market had a market share of USD 29.15 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. India's increasing healthcare investments and initiatives aimed at enhancing cancer treatment infrastructure and technology adoption are driving the market growth for Tumor Radiation Therapy.
• The South Korea Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 24.29 million in 2024.
• The Australia Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 12.63 million in 2024.
• The South East Asia Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 16.76 million in 2024.
• The Rest of Asia Pacific Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 17.25 million in 2024.

South America Tumor Radiation Therapy

According to Cognitive Market Research, the global Tumor Radiation Therapy Market size was estimated at USD 1056.25 Million, out of which Latin America held the market of around 5% of the global revenue with a market size of USD 52.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Tumor Radiation Therapy Market size was valued at USD 22.60 million in 2024 and is projected to grow at a CAGR of 5.50% during the forecast period. Tumor Radiation Therapy sales flourished in Brazil due to the significant government investments in healthcare infrastructure and initiatives to expand access to advanced cancer treatment technologies
• Argentina Tumor Radiation Therapy Market had a market share of USD 8.87 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. In Argentina, ongoing advancements in healthcare infrastructure and increasing adoption of advanced radiation therapy technologies are boosting market growth.
• Colombia Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 4.70 million in 2024.
• Peru Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 4.33 million in 2024.
• The Chile Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 3.80 million in 2024.
• The Rest of Latin America Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 8.50 million in 2024.

Middle East and Africa Tumor Radiation Therapy

According to Cognitive Market Research, the global Tumor Radiation Therapy Market size was estimated at USD 1056.25 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 21.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• The GCC Countries Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 9.04 million in 2024. Tumor Radiation Therapy sales flourish due to the significant investments in healthcare infrastructure, including state-of-the-art cancer treatment centers and advanced radiation therapy technologies.
• The Egypt Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 2.22 million in 2024
• The South Africa Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 3.34 million in 2024. Tumor Radiation Therapy sales flourish in South Africa due to the rising incidence of cancer, prompting increased demand for advanced treatment options and supporting market growth.
• The Turkey Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 1.82 million in 2024.
• The Nigeria Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 2.22 million in 2024.
• The Rest of the MEA Tumor Radiation Therapy Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 2.49 million in 2024.

Tumor Radiation Therapy Market Analysis

Tumor Radiation Therapy Market Type Segment Analysis

According to Cognitive Market Research, the External Beam Radiation Therapy (EBRT) subsegment holds the largest share. EBRT is the most widely used form of radiation therapy and involves targeting cancerous tumors with high-energy radiation beams from outside the body. EBRT's versatility in treating a wide range of cancers, including breast, prostate, lung, and head and neck cancers, makes it a preferred choice among healthcare providers. The ability to precisely target tumors while sparing surrounding healthy tissue enhances its efficacy and safety, contributing to its widespread adoption. Furthermore, continuous advancements in EBRT technology, such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT), have significantly improved treatment precision and outcomes, driving its market share.

Systemic Radiation Therapy is the fastest-growing subsegment in the Tumor Radiation Therapy market. Systemic radiation therapy involves the administration of radioactive substances, such as radiopharmaceuticals that travel through the bloodstream to target cancer cells throughout the body. Systemic radiation therapy is particularly effective for treating cancers that have metastasized or are difficult to target with localized treatments like EBRT or internal beam therapy. The ability to deliver radiation to dispersed cancer cells provides a comprehensive treatment approach, making it a valuable option for advanced-stage cancers. Additionally, the expanding applications of systemic radiation therapy in treating various cancer types, including prostate cancer, neuroendocrine tumors, and certain types of lymphoma, are contributing to its rapid growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Tumor Radiation Therapy Industry. Request a Free Sample PDF!

Tumor Radiation Therapy Market Application Segment Analysis

According to Cognitive Market Research, Breast Cancer dominates the Tumor Radiation Therapy Market. Breast cancer is one of the most prevalent cancers worldwide, affecting millions of women each year. The high incidence rate, coupled with the effectiveness of radiation therapy as a treatment option, drives the significant share of this subsegment. Additionally, advancements in radiation techniques, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have improved the precision and safety of treatments, enhancing patient outcomes and boosting adoption. Moreover, the substantial investment in breast cancer research and the development of specialized radiation therapy equipment tailored for breast cancer treatment contribute to the dominance of this subsegment. Public awareness campaigns and screening programs have led to early detection and increased treatment rates, further expanding the market for breast cancer radiation therapy.

Prostate Cancer is emerging as the fastest-growing subsegment in the Tumor Radiation Therapy market. Prostate cancer is one of the most common cancers among men, with incidence rates increasing due to aging populations and improved screening methods. The rising prevalence of prostate cancer necessitates effective treatment options, positioning radiation therapy as a critical intervention. Radiation therapy, including external beam radiation therapy (EBRT) and brachytherapy, is widely used in treating localized and advanced prostate cancer. Additionally, the growing emphasis on personalized medicine and precision oncology has led to tailored radiation therapy approaches for prostate cancer patients, further enhancing treatment outcomes.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Tumor Radiation Therapy End User Segment Analysis

Tumor Radiation Therapy Market End User Segment Analysis

According to Cognitive Market Research, the Hospitals segment currently dominates the Tumor Radiation Therapy market. Hospitals are typically the primary healthcare providers offering comprehensive cancer care, including radiation therapy, surgery, and chemotherapy. The integration of various oncology services under one roof provides patients with coordinated and multidisciplinary care, enhancing treatment outcomes. Hospitals generally have more substantial financial resources to invest in state-of-the-art radiation therapy equipment and technologies. This enables them to adopt advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy. Moreover, hospitals are often part of larger healthcare systems, allowing for better access to funding, research, and development activities that drive innovation in cancer treatment.

Independent Radiotherapy Centers are emerging as the fastest-growing subsegment in the Tumor Radiation Therapy market. Independent radiotherapy centers specialize exclusively in providing radiation therapy services, offering focused and high-quality care. The increasing demand for outpatient cancer treatment options is driving the expansion of independent radiotherapy centers. These centers provide a convenient alternative for patients who prefer receiving radiation therapy outside the hospital setting. The ability to offer flexible scheduling, reduced waiting times, and a patient-centered approach enhances the appeal of independent radiotherapy centers. Moreover, advancements in radiation therapy technology have made it feasible for smaller, specialized centers to provide high-quality care. Independent radiotherapy centers can now acquire advanced equipment and technologies, such as linear accelerators and advanced imaging systems, enabling them to deliver precise and effective treatments.

• Hospitals
• Independent Radiotherapy Centers

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion